Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Catalytically Perfect Enzymes01:07

Catalytically Perfect Enzymes

The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and are...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same author

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

EMBO reports·2026
Same author

Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition.

iScience·2025
Same author

Leishmania donovani's protein tyrosine phosphatases interact with DUF21 and respond to environmental magnesium.

The FEBS journal·2025
Same author

Translon: a single term for translated regions.

Nature methods·2025
Same author

Impact of culture vessel materials on biomanufacturing of dendritic cell-based immunotherapies in closed systems.

Biomaterials science·2025
Same journal

Conformational mobility of cationic voltage-gated ion channels.

Critical reviews in biochemistry and molecular biology·2026
Same journal

DNA polymerase I: structure, activity, and function in bacterial DNA replication and repair.

Critical reviews in biochemistry and molecular biology·2026
Same journal

The impact of HIV-1 Nef on CD4<sup>+</sup> T cells.

Critical reviews in biochemistry and molecular biology·2026
Same journal

Recent insights into bacterial ESCRT-III-mediated membrane remodeling.

Critical reviews in biochemistry and molecular biology·2026
Same journal

CRISPR-Cas9 editing of agricultural crops and medicinal plants: toward a cornucopia of natural products.

Critical reviews in biochemistry and molecular biology·2025
Same journal

RNA modifications as a means of self-recognition and immune protection.

Critical reviews in biochemistry and molecular biology·2025
See all related articles

Related Experiment Video

Updated: May 9, 2026

Real-Time Quantification of the Effects of IS200/IS605 Family-Associated TnpB on Transposon Activity
04:04

Real-Time Quantification of the Effects of IS200/IS605 Family-Associated TnpB on Transposon Activity

Published on: January 20, 2023

PTP1B: a simple enzyme for a complex world.

Matthew Feldhammer1, Noriko Uetani, Diego Miranda-Saavedra

  • 1Goodman Cancer Research Center .

Critical Reviews in Biochemistry and Molecular Biology
|July 25, 2013
PubMed
Summary
This summary is machine-generated.

Protein tyrosine phosphatase 1B (PTP1B) is a key regulator in cellular signaling, impacting metabolic diseases, cancer, and immune responses. This review explores PTP1B's roles and therapeutic potential.

More Related Videos

Tandem Affinity Purification of Protein Complexes from Eukaryotic Cells
11:30

Tandem Affinity Purification of Protein Complexes from Eukaryotic Cells

Published on: January 26, 2017

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
09:26

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

Published on: December 29, 2021

Related Experiment Videos

Last Updated: May 9, 2026

Real-Time Quantification of the Effects of IS200/IS605 Family-Associated TnpB on Transposon Activity
04:04

Real-Time Quantification of the Effects of IS200/IS605 Family-Associated TnpB on Transposon Activity

Published on: January 20, 2023

Tandem Affinity Purification of Protein Complexes from Eukaryotic Cells
11:30

Tandem Affinity Purification of Protein Complexes from Eukaryotic Cells

Published on: January 26, 2017

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
09:26

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

Published on: December 29, 2021

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Biochemistry

Background:

  • Tyrosine phosphatases, particularly PTP1B, have complex regulatory roles beyond simple "off" switches for tyrosine kinases.
  • PTP1B is a critical regulator of insulin and leptin signaling, implicating it in type II diabetes and obesity.
  • PTP1B functions as both a tumor suppressor and promoter in cancer, depending on the cellular context.

Purpose of the Study:

  • To review the evolutionary emergence and physiological control of PTP1B.
  • To explore PTP1B's multifaceted roles in metabolic syndromes, cancer, and immune signaling.
  • To examine novel therapeutic strategies targeting PTP1B.

Main Methods:

  • Literature review of evolutionary, cellular, and systemic studies on PTP1B.
  • Analysis of PTP1B's involvement in key signaling pathways, including JAK-STAT.
  • Examination of PTP1B's role in disease pathogenesis and therapeutic interventions.

Main Results:

  • PTP1B is a significant negative regulator of Janus kinase - signal transducer and activator of transcription (JAK-STAT) signaling.
  • PTP1B acts as a crucial link between metabolic diseases, inflammation, and immune responses.
  • PTP1B's dual role in cancer and its regulation of metabolic receptors highlight its therapeutic relevance.

Conclusions:

  • PTP1B is a pivotal enzyme with diverse roles in cellular homeostasis and disease.
  • Understanding PTP1B's regulation of immune signaling offers new insights into metabolic diseases and cancer.
  • Targeting PTP1B presents a promising avenue for developing novel therapeutics.